<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12779</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12779</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Цереброваскулярная патология у больных резистентной артериальной гипертонией в сочетании с сахарным диабетом 2 типа</article-title><trans-title-group xml:lang="en"><trans-title>Cerebrovascular disorders in patients with type 2 diabetes mellitus and resistant hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5638-3034</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фальковская</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Falkovskaya</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фальковская Алла Юрьевна, кандидат медицинских наук</p><p>634012, Томск, ул. Киевская, д. 111А</p><p>eLibrary SPIN: 1418-2726</p></bio><bio xml:lang="en"><p>Alla Yu. Falkovskaya, MD, PhD</p><p>111а, Kievskaya st., 634012 Tomsk</p><p>eLibrary SPIN: 1418-2726</p></bio><email xlink:type="simple">alla@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2238-4573</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мордовин</surname><given-names>В. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Mordovin</surname><given-names>V. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мордовин Виктор Федорович, доктор медицинских наук , профессор</p><p>Томск</p><p>eLibrary SPIN: 4948-0425</p></bio><bio xml:lang="en"><p>Victor F. Mordovin, MD, PhD, Professor</p><p>Tomsk</p><p>eLibrary SPIN: 4948-0425</p></bio><email xlink:type="simple">mordovin@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4807-3762</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сухарева</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Sukhareva</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сухарева Анна Евгеньевна, кандидат медицинских наук</p><p>Томск</p><p>eLibrary SPIN: 7914-3111</p></bio><bio xml:lang="en"><p>Anna E. Sukhareva, MD, PhD</p><p>Tomsk</p><p>eLibrary SPIN: 7914-3111</p></bio><email xlink:type="simple">doctor-Anyuta@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6995-9875</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зюбанова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyubanova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зюбанова Ирина Владимировна, кандидат медицинских наук</p><p>Томск</p><p>eLibrary SPIN: 9032-8376</p></bio><bio xml:lang="en"><p>Irina V. Zyubanova, MD, PhD</p><p>Tomsk</p><p>eLibrary SPIN: 9032-8376</p></bio><email xlink:type="simple">zyubanovaiv@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3577-1895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манукян</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Manukyan</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Манукян Мушег Айкович, аспирант</p><p>Томск</p><p>eLibrary SPIN: 3993-1733</p></bio><bio xml:lang="en"><p>Musheg A. Manukyan, MD, PhD student</p><p>Tomsk</p><p>eLibrary SPIN: 3993-1733</p></bio><email xlink:type="simple">manukyan.muscheg@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4066-869X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Личикаки</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lichikaki</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Личикаки Валерия Анатольевна, кандидат медицинских наук</p><p>Томск</p><p>eLibrary SPIN: 6551-7304</p></bio><bio xml:lang="en"><p>Valerya A. Lichikaki, MD, PhD</p><p>Tomsk</p><p>eLibrary SPIN: 6551-7304</p></bio><email xlink:type="simple">manankovalera@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9857-4368</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цой</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsoi</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цой Екатерина Игоревна, кандидат медицинских наук</p><p>Томск</p><p>eLibrary SPIN: 5739-0105</p></bio><bio xml:lang="en"><p>Ekaterina I. Tsoy, MD, PhD</p><p>Tomsk</p><p>eLibrary SPIN: 5739-0105</p></bio><email xlink:type="simple">haksen_sgmu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3147-3025</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусакова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Gusakova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гусакова Анна Михайловна, кандидат физических наук</p><p>Томск</p><p>eLibrary SPIN: 6513-2800</p></bio><bio xml:lang="en"><p>Anna M. Gusakova, PhD in Pharmacy</p><p>Tomsk</p><p>eLibrary SPIN: 6513-2800</p></bio><email xlink:type="simple">anna@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дорожкина</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dorozhkina</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дорожкина Наталья Викторовна </p><p>Томск</p></bio><bio xml:lang="en"><p>Natalya V. Dorozhkina, laboratory assistant</p><p>Tomsk</p></bio><email xlink:type="simple">dorojckina.nataliya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>03</month><year>2022</year></pub-date><volume>25</volume><issue>2</issue><fpage>128</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фальковская А.Ю., Мордовин В.Ф., Сухарева А.Е., Зюбанова И.В., Манукян М.А., Личикаки В.А., Цой Е.И., Гусакова А.М., Дорожкина Н.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Фальковская А.Ю., Мордовин В.Ф., Сухарева А.Е., Зюбанова И.В., Манукян М.А., Личикаки В.А., Цой Е.И., Гусакова А.М., Дорожкина Н.В.</copyright-holder><copyright-holder xml:lang="en">Falkovskaya A.Y., Mordovin V.F., Sukhareva A.E., Zyubanova I.V., Manukyan M.A., Lichikaki V.A., Tsoi E.I., Gusakova A.M., Dorozhkina N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12779">https://www.dia-endojournals.ru/jour/article/view/12779</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Сахарный диабет (СД) и артериальная гипертония (АГ) относятся к независимым детерминантам риска мозгового инсульта, а их сочетание многократно повышает частоту церебральных осложнений. Выявление факторов, связанных с развитием доклинических повреждений головного мозга, может изменить терапевтическую стратегию предупреждения развития мозговых катастроф. Тем не менее, данных по этому вопросу для больных СД в сочетании с резистентной АГ (РАГ) по-прежнему недостаточно.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Изучить характер церебрососудистых изменений по данным магнитно-резонансной томографии (МРТ) головного мозга у больных СД 2 типа (СД2) в сочетании с РАГ и выявить факторы, вовлеченные в их развитие.</p></sec><sec><title>МАТЕРИАЛЫ И МЕТОДЫ</title><p>МАТЕРИАЛЫ И МЕТОДЫ. В одноцентровое наблюдательное одномоментное одновыборочное неконтролируемое исследование включены 46 больных СД2 с РАГ. Анализировали данные МРТ головного мозга (1,5 Тесла) с измерениями индекса Эванса (ИЭ), общеклинические и лабораторные показатели (глюкоза, инсулин, С-пептид, лептин, резистин, альдостерон, высокочувствительный С-реактивный белок (вчСРБ), фактор некроза опухоли альфа (ФНО-альфа), инсулиноподобный фактор роста-1 (ИПФР-1)), офисное и среднесуточное артериальное давление (АД), периферическую и церебральную вазореактивность (тест с гипервентиляцией и задержкой дыхания).</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Наиболее частыми МРТ-изменениями были расширения желудочков (45%) и субарахноидальных пространств (65%), повреждения белого вещества (ПБВ) фокального характера (52%) и в перивентрикулярной области (ПВО) (89%). Выявлены множественные прямые корреляционные взаимосвязи показателей углеводного обмена (гликированный гемоглобин, глюкоза, инсулин, С-пептид) со степенью ПБВ в ПВО, плотностью МРТ-сигнала от базальных ядер и значениями ИЭ. Уровни адипокинов имели прямую связь с поперечным размером хиазмальной цистерны и значениями ИЭ (для резистина), а также с плотностью МРТ-сигнала от базальных ядер и с увеличением ИЭ (для лептина). Увеличение значений ИЭ было дополнительно взаимосвязано с возрастанием уровня ИПФР-1. Уровень альдостерона коррелировал с поперечным размером III желудочка. Повышение концентраций ФНО-α и вчСРБ сопровождалось увеличением плотности МРТ-сигнала в ПВО. Нарушение цереброваскулярной реактивности было связано с повышением плотности МРТ-сигнала в ПВО и выраженностью косвенных признаков атрофии головного мозга (увеличение ИЭ, расширение цистерн, боковых желудочков). Снижение периферической вазореактивности ассоциировалось с увеличением значений ИЭ и расширением III желудочка. Прямых корреляционных связей выраженности структурных изменений головного мозга с показателями АД не обнаружено.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Для сочетания СД2 с РАГ характерна высокая частота повреждения белого вещества и расширения ликворных пространств, выраженность которых коррелирует с тяжестью метаболических, нейрогормональных и гемодинамических расстройств в отсутствие прямой связи со степенью повышения АД.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Diabetes mellitus (DM) and hypertension are risk factors for cerebral stroke, which are exacerbated by the combination of these diseases. Identifying the factors involved in the development of subclinical brain damage could change the therapeutic strategy for protecting the brain.</p></sec><sec><title>AIM</title><p>AIM: to study severity of MRI- sings of brain damage and to identify factors associated with their development in patients with type 2 diabetes and RHTN.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: 46 patients with type 2 DM and RHTN were included in a single-center observational uncontrolled study. Patients underwent brain MRI (1.5 Tesla) with calculation of Evans’s index (EI), clinical and lab examinations (HbA1c, glucose, insulin, C-peptide, leptin, resistin, TNF- α, hsCRP, blood aldosterone, insulin-like growth factor-1 (IGF-1)), measurement of the office and ambulatory blood pressure (BP), assessment of peripheral and cerebral vasoreactivity (test with hyperventilation and breath holding).</p></sec><sec><title>RESULTS</title><p>RESULTS: The most frequent MR brain changes were white matter lesions (WML) in periventricular region (PVR) (89%), focal WML (52%) and expansion both of the ventricles (45%) and subarachnoid spaces (65%). Multiple direct correlations were revealed between parameters of carbohydrate metabolism with the degree of WML in PVR and the density of the MR-signal in the basal nucleus (BN), as well as with EI. Adipokines had a direct relationship with the size of the chiasmatic cistern and IE (for resistin), as well as with the density of the MR signal from the BN and IE (for leptin), that was also directly related to the IGF-1 level. The aldosterone level positively correlated with the size of III ventricle. An increase in TNF-α and hsCRP was accompanied by an increase in the density of the MR-signal in the PVR. Impairment of cerebrovascular reactivity is associated with an increase in the density of the MR-signal in PVR and with indirect signs of cerebral atrophy (increase in EI, the size of cisterns and lateral ventricles). Impairment of peripheral vasoreactivity had direct relationship with EI and the expansion of the III ventricle. There were no direct correlations between the severity of MR-sings of brain damage and BP levels.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION: The combination of type 2 DM with RHTN is characterized by a high frequency of WML and liquorodynamics disturbances, which related with metabolic, neurohormonal and hemodynamic factors in the absence of a direct relationship with the degree of BP increase</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>резистентная артериальная гипертония</kwd><kwd>МРТ головного мозга</kwd><kwd>церебрососудистая патология</kwd><kwd>цитокины</kwd><kwd>адипокины</kwd><kwd>вазореактивность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>resistant hypertension</kwd><kwd>brain MRI</kwd><kwd>cerebrovascular disease</kwd><kwd>cytokines</kwd><kwd>adipokines</kwd><kwd>vasoreactivity</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет средств Гос. задания НИИК Томского НИМЦ, гос. регистрация: АААА-А15-115123110026-3 от 31.12.2015</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Шестакова М.В., Викулова О.К., и др. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. // Сахарный диабет. — 2019. — Т. 22. — №2S. — С. 4-61. doi: https://doi.org/10.14341/DM12208</mixed-citation><mixed-citation xml:lang="en">Dedov II, Shestakova MV, Vikulova OK, et al. Atlas of Diabetes Register in Russian Federation, status 2018. Diabetes mellitus. 2019;22(2S):4-61. (In Russ.). doi: https://doi.org/10.14341/DM12208</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Калашникова М.Ф., Белоусов Д.Ю., и др. Анализ стоимости болезни сахарного диабета 2 типа в Российской Федерации: результаты Российского многоцентрового наблюдательного фармакоэпидемиологического исследования ФОРСАЙТ-СД2 // Сахарный диабет. — 2017. — Т. 20. — №6. — С. 403-419. doi: https://doi.org/10.14341/DM9278</mixed-citation><mixed-citation xml:lang="en">Dedov II, Kalashnikova MF, Belousov DY, et al. Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM). Diabetes mellitus. 2017;20(6):403-419. (In Russ.). doi: https://doi.org/10.14341/DM9278</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222. doi: https://doi.org/10.1016/S0140-6736(10)60484-9</mixed-citation><mixed-citation xml:lang="en">Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222. doi: https://doi.org/10.1016/S0140-6736(10)60484-9</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327-338. doi: https://doi.org/10.2147/DMSO.S51325</mixed-citation><mixed-citation xml:lang="en">Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327-338. doi: https://doi.org/10.2147/DMSO.S51325</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Jiang X, Bo J, et al. Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients. Journal of Hypertension. 2018;36(1):93-100. doi: https://doi.org/10.1097/HJH.0000000000001528</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Jiang X, Bo J, et al. Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients. Journal of Hypertension. 2018;36(1):93-100. doi: https://doi.org/10.1097/HJH.0000000000001528</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Рюмшина Н.И., Баев А.Е., Фальковская А.Ю. и др. МРТ сосудистой стенки с парамагнитным контрастным усилением в оценке терапевтического воздействия радиочастотной абляции симпатических сплетений почечных артерий при лечении резистентной артериальной гипертонии // Медицинская визуализация. — 2019. — №1. — С. 56-64. doi: https://doi.org/10.24835/1607-0763-2019-1-56-64</mixed-citation><mixed-citation xml:lang="en">Ryumshina NI, Baev A, Falkovskaya AYu, et al. MRI with paramagnetic contrast enhancement of the arterial vascular wall in follow-up control of therapeutic effect in resistant arterial hypertension treated with radiofrequency ablation of sympathetic plexus of the renal arteries. Medical Visualization. 2019;(1):56-64. (In Russ.). doi: https://doi.org/10.24835/1607-0763-2019-1-56-64</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Усов В.Ю., Ярошевский С.П., Тлюняева А.М., и др. Сочетанное применение количественной обработки Т2-взвешенных изображений и МРТ-кортикометрии у пациентов с атеросклерозом сонных артерий для прогнозирования церебральных осложнений инвазивных и хирургических вмешательств // Лучевая диагностика и терапия. — 2018. — №4. — С. 48-56. doi: https://doi.org/10.22328/2079-5343-2018-4-48-56</mixed-citation><mixed-citation xml:lang="en">Usov WYu, Yaroshevsky SP, Tlyuniaeva AM, et al. Quantitative processing of T2-weighted cerebral MRI concomitant with thin-slice cortex measurements in patients with severe carotid atherosclerosis for prognosis of cerebral complications after invasive cardiovascular interventions. Diagnostic radiology and radiotherapy. 2018;4:48-56. (In Russ.). doi: https://doi.org/10.22328/2079-5343-2018-4-48-56</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Debette S, Schilling S, Duperron MG, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurology. 2019;76(1):81-94. doi: https://doi.org/10.1001/jamaneurol.2018.3122</mixed-citation><mixed-citation xml:lang="en">Debette S, Schilling S, Duperron MG, et al. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurology. 2019;76(1):81-94. doi: https://doi.org/10.1001/jamaneurol.2018.3122</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гребенников Д.А., Ситников Е.В., Ананьев В.К. Дифференциальная диагностика гидроцефалии и атрофии головного мозга // Здравоохранение Дальнего Востока. — 2017. — Т. 72. — №2. — С. 51-54.</mixed-citation><mixed-citation xml:lang="en">Grebennikov DA, Sitnikov EV, Ananyev VK. Differential diagnosis of brain atrophy and hydrocephaly. Public health of the Far East. 2017;72(2):51-54. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology. 2018;34(5):575-584. doi: https://doi.org/10.1016/j.cjca.2017.12.005</mixed-citation><mixed-citation xml:lang="en">Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology. 2018;34(5):575-584. doi: https://doi.org/10.1016/j.cjca.2017.12.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-980. doi: https://doi.org/10.1016/S0140-6736(21)01330-1</mixed-citation><mixed-citation xml:lang="en">Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-980. doi: https://doi.org/10.1016/S0140-6736(21)01330-1</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammad А, Abujbara М, Alshraideh J, et al. The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics. Journal of Endocrinology and Metabolism. 2017;7(5):153-158. doi: https://doi.org/10.14740/jem448e</mixed-citation><mixed-citation xml:lang="en">Mohammad А, Abujbara М, Alshraideh J, et al. The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics. Journal of Endocrinology and Metabolism. 2017;7(5):153-158. doi: https://doi.org/10.14740/jem448e</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Schneider ALC, Selvin E, Sharrett AR, et al. Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). Diabetes Care. 2017;40:1514-1521. doi: https://doi.org/10.2337/dc17-1185.</mixed-citation><mixed-citation xml:lang="en">Schneider ALC, Selvin E, Sharrett AR, et al. Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS). Diabetes Care. 2017;40:1514-1521. doi: https://doi.org/10.2337/dc17-1185.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ogama N, Sakurai T, Kawashima S, et al. Postprandial hyperglycemia is associated with white matter hyperintensity and brain atrophy in older patients with type 2 diabetes mellitus. Front. Aging Neurosci. 2018;10:273. doi: https://doi.org/10.3389/fnagi.2018.00273</mixed-citation><mixed-citation xml:lang="en">Ogama N, Sakurai T, Kawashima S, et al. Postprandial hyperglycemia is associated with white matter hyperintensity and brain atrophy in older patients with type 2 diabetes mellitus. Front. Aging Neurosci. 2018;10:273. doi: https://doi.org/10.3389/fnagi.2018.00273</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;(65):252-256. doi: https://doi.org/10.1161/HYPERTENSIONAHA.114.03617</mixed-citation><mixed-citation xml:lang="en">Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;(65):252-256. doi: https://doi.org/10.1161/HYPERTENSIONAHA.114.03617</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Climie RE, Moran C, Callisaya M, et al. Abdominal Obesity and Brain Atrophy in Type 2 Diabetes Mellitus. PLoS One. 2015;10(11):e0142589. doi: https://doi.org/10.1371/journal.pone.0142589</mixed-citation><mixed-citation xml:lang="en">Climie RE, Moran C, Callisaya M, et al. Abdominal Obesity and Brain Atrophy in Type 2 Diabetes Mellitus. PLoS One. 2015;10(11):e0142589. doi: https://doi.org/10.1371/journal.pone.0142589</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660-667. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.07802</mixed-citation><mixed-citation xml:lang="en">Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660-667. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.07802</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cuadrado-Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. Journal of Stroke. 2018;20(3):302. doi: https://doi.org/10.5853/jos.2017.02922</mixed-citation><mixed-citation xml:lang="en">Cuadrado-Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. Journal of Stroke. 2018;20(3):302. doi: https://doi.org/10.5853/jos.2017.02922</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ni Y, Teng T, Li R, et al. TNF-α alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS One. 2017;12(2):e0170346. doi: https://doi.org/10.1371/journal.pone.0170346</mixed-citation><mixed-citation xml:lang="en">Ni Y, Teng T, Li R, et al. TNF-α alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS One. 2017;12(2):e0170346. doi: https://doi.org/10.1371/journal.pone.0170346</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Зюбанова И.В., Мордовин В.Ф., Пекарский С.Е., и др. Возможные механизмы отдаленных кардиальных эффектов ренальной денервации // Артериальная гипертензия. — 2019. — Т. 25. — №4. — С. 423-432. doi: https://doi.org/10.18705/1607-419X-2019-25-4-423-432</mixed-citation><mixed-citation xml:lang="en">Zyubanova IV, Mordovin VF, Pekarskiy SE, et al. Possible mechanisms of renal denervation long-term cardiac effects. Arterial Hypertension. 2019;25(4):423-432. (In Russ.). doi: https://doi.org/10.18705/1607-419X-2019-25-4-423-432</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
